Tutin L - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma.

Gollob JA, Veenstra KG, Parker RA, Mier JW, McDermott DF, Clancy D, Tutin L, Koon H, Atkins MB. Gollob JA, et al. Among authors: tutin l. J Clin Oncol. 2003 Jul 1;21(13):2564-73. doi: 10.1200/JCO.2003.12.119. J Clin Oncol. 2003. PMID: 12829677 Clinical Trial.

A phase II pilot trial of concurrent biochemotherapy with cisplatin, vinblastine, temozolomide, interleukin 2, and IFN-alpha 2B in patients with metastatic melanoma.

Atkins MB, Gollob JA, Sosman JA, McDermott DF, Tutin L, Sorokin P, Parker RA, Mier JW. Atkins MB, et al. Among authors: tutin l. Clin Cancer Res. 2002 Oct;8(10):3075-81. Clin Cancer Res. 2002. PMID: 12374674 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters